Genetic tests for predicting suicide

“Relief could be on the way for those concerned that taking antidepressants could increase the risk of suicide.”

NeuroMark announced in October the immediate availability of a genetic test to identify people at risk of suicidal ideation — thoughts of committing suicide — when prescribed an antidepressant drug. The test, called the Mark-C™ test, is expected to help restore public confidence in antidepressant medication and help to reduce a recently announced spike in suicide rates among the American youth.”


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s